• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Closing Thoughts About IgA Nephropathy Treatment

Opinion
Video

Panelists discuss how the management of immunoglobulin A (IgA) nephropathy is undergoing a transformative shift from symptom control to targeted disease modification, with emerging therapies offering new hope for patients while requiring thoughtful integration into clinical practice and health care systems.

Related Videos
Dr Susan Vadaparampil
Dr Ameet Patel
5 experts are featured in this series
5 experts are featured in this series
Glaucoma awareness month | Image credit: khaled - stock.adobe.com
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.